Study sharpens CRH diagnosis in Golden Retrievers

A newly highlighted Veterinary Dermatology report focuses on a familiar diagnostic problem in canine dermatopathology: how to confidently identify cutaneous reactive histiocytosis in dogs when routine histology overlaps with other inflammatory skin diseases. In 11 Golden Retrievers with lesions compatible with cutaneous reactive histiocytosis, the authors used immunohistochemical staining and found a consistent pattern of strong Iba1 positivity with no staining from a macrophage antibody cocktail, supporting a dendritic cell origin for the infiltrating histiocytes and confirming the diagnosis. (eurekamag.com)

That matters because reactive histiocytosis has long sat in a diagnostically messy space. Earlier work has described canine reactive histiocytosis as a non-neoplastic proliferative disorder of activated interstitial dendritic cells that may be limited to skin, subcutis, and draining lymph nodes in the cutaneous form, or extend to mucosal, ocular, or visceral sites in systemic disease. Clinical lesions can overlap with other nodular or plaque-like dermatoses, and histopathology alone may not always cleanly separate CRH from granulomatous inflammation, infection, or inflamed cutaneous lymphoma. (onlinelibrary.wiley.com)

The study’s core contribution is methodological. According to the abstract, the team evaluated paraffin-embedded skin biopsy samples from 11 Golden Retrievers with confirmed CRH using Iba1 and a validated macrophage antibody panel. The combination of diffuse Iba1 labeling and absence of macrophage marker staining supported a dendritic cell phenotype. That’s a useful refinement rather than a wholesale redefinition: a 2014 study had already shown that Iba1 is broadly expressed in canine reactive histiocytosis, but also in macrophages and other histiocytic disorders, meaning Iba1 alone is informative but not necessarily specific. The newer Golden Retriever paper appears to improve specificity by pairing Iba1 with negative macrophage-marker results. (eurekamag.com)

The findings also fit with the broader diagnostic framework used in recent reactive histiocytosis literature. A 2026 retrospective case series on oclacitinib noted that definitive diagnosis still requires compatible histologic features and exclusion of infectious agents or inflamed non-epitheliotropic cutaneous T-cell lymphoma, while immunohistochemistry can help characterize the cells as interstitial dendritic cells. In that paper, reactive histiocytosis lesions were described as Iba1-positive and lacking markers associated with other lineages, underscoring how immunophenotyping is increasingly part of the workup, not just an academic add-on. (onlinelibrary.wiley.com)

Direct outside commentary on this specific paper was limited in the public record, but the surrounding literature points in the same direction: immunohistochemistry is becoming more important in sorting histiocytic and histiocyte-rich skin lesions. A recent review on cutaneous histiocytosis said immunohistochemical staining is warranted in support of standard pathology, especially given persistent classification and treatment pitfalls. That aligns with what many dermatologists and pathologists already see in practice, where morphology, clinical pattern, and targeted staining all need to be interpreted together. (pubmed.ncbi.nlm.nih.gov)

Why it matters: For veterinary professionals, this is less about a new disease than a better diagnostic tool for an uncommon, easily confused one. If the Iba1-positive, macrophage-negative pattern holds up, it could help pathologists and clinicians narrow differentials faster, reduce diagnostic uncertainty for pet parents, and support earlier treatment decisions. That’s especially relevant as therapeutic discussions evolve. Historical case series have documented varied management approaches, including prednisone-based regimens, tetracycline/niacinamide, cyclosporine, and other therapies, while more recent reports are exploring options such as oclacitinib in selected reactive histiocytosis cases. Better classification upstream may make those downstream treatment decisions more rational. (onlinelibrary.wiley.com)

The breed focus is also notable. Golden Retrievers appear in the histiocytic disease literature, including reports involving reactive and neoplastic histiocytic conditions, although systemic histiocytosis is more classically associated with Bernese Mountain Dogs. This paper doesn’t establish breed-specific causation, but it does suggest that when Golden Retrievers present with compatible nodular or plaque-like skin disease, CRH should remain on the differential and may merit immunohistochemical confirmation. (dvm360.com)

What to watch: The next step is external validation, particularly in larger, multi-breed cohorts and in head-to-head comparisons with infectious granulomatous disease, histiocytoma, histiocytic sarcoma, and cutaneous lymphoma. If future studies confirm that this staining pattern reliably improves specificity on routine biopsy material, it could become a more standard part of dermatopathology panels for difficult canine skin cases. (pubmed.ncbi.nlm.nih.gov)